Rentschler Biopharma SE

Activities: Pharmaceutical

Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO), focused exclusively on client projects.

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  5. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Manufacturing

Rentschler Biopharma appoint Senta Brandt and Gerrick Rodrigues to Global Leadership Positions

Senta Brandt and Gerrick Rodrigues claim the Head of Transformation and Global Head of IT positions at Rentschler respectively
Drug Delivery

Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board

Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including Advanced Therapy Medicinal Products (ATMPs), announced today that Gunnar Voss von Dahlen (54) has been appointed as Chief Financial Officer, effective December 1, 2023
Manufacturing

Rentschler Biopharma appoints Head of Digital Manufacturing and Automation

Before joining Rentschler Biopharma, Thomas aus dem Siepen worked for 16 years in management positions at Roche Diagnostics
Marketing

Rentschler and Vetter unveil collaboration visualisation

In mid-2020, the companies entered a strategic alliance with the goal of helping clients bring complex products to patients faster and more easily
Manufacturing

Rentschler Biopharma and Vetter unveil Xpert Alliance, a joint visualization of their successful strategic collaboration

The visualisation is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex biopharmaceuticals
Finance

Rentschler appoints General Manager of UK ATMP unit

Dr Robert Panting joins the company from Fujifilm Diosynth Biotechnologies, where he worked in project management, customer management and business planning
Finance

Rentschler Biopharma supports construction of Einstein centre

To implement the project, the ‘First 11’ campaign aims to motivate more companies to become sponsors
Subscribe now